Literature DB >> 25220454

Origin-dependent neural cell identities in differentiated human iPSCs in vitro and after transplantation into the mouse brain.

Gunnar Hargus1, Marc Ehrlich1, Marcos J Araúzo-Bravo2, Kathrin Hemmer3, Anna-Lena Hallmann1, Peter Reinhardt4, Kee-Pyo Kim4, Kenjiro Adachi4, Simeon Santourlidis5, Foued Ghanjati5, Mareike Fauser6, Christiana Ossig6, Alexander Storch6, Jeong Beom Kim7, Jens C Schwamborn3, Jared Sterneckert4, Hans R Schöler8, Tanja Kuhlmann9, Holm Zaehres4.   

Abstract

The differentiation capability of induced pluripotent stem cells (iPSCs) toward certain cell types for disease modeling and drug screening assays might be influenced by their somatic cell of origin. Here, we have compared the neural induction of human iPSCs generated from fetal neural stem cells (fNSCs), dermal fibroblasts, or cord blood CD34(+) hematopoietic progenitor cells. Neural progenitor cells (NPCs) and neurons could be generated at similar efficiencies from all iPSCs. Transcriptomics analysis of the whole genome and of neural genes revealed a separation of neuroectoderm-derived iPSC-NPCs from mesoderm-derived iPSC-NPCs. Furthermore, we found genes that were similarly expressed in fNSCs and neuroectoderm, but not in mesoderm-derived iPSC-NPCs. Notably, these neural signatures were retained after transplantation into the cortex of mice and paralleled with increased survival of neuroectoderm-derived cells in vivo. These results indicate distinct origin-dependent neural cell identities in differentiated human iPSCs both in vitro and in vivo.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25220454     DOI: 10.1016/j.celrep.2014.08.014

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  22 in total

Review 1.  Concise Review: Human-Animal Neurological Chimeras: Humanized Animals or Human Cells in an Animal?

Authors:  Andrew T Crane; Joseph P Voth; Francis X Shen; Walter C Low
Journal:  Stem Cells       Date:  2019-01-28       Impact factor: 6.277

Review 2.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

Review 3.  Retention of Somatic Memory Associated with Cell Identity, Age and Metabolism in Induced Pluripotent Stem (iPS) Cells Reprogramming.

Authors:  Tze Sean Khoo; Rahman Jamal; Nur Azurah Abdul Ghani; Hafiza Alauddin; Noor Hamidah Hussin; Nor Azian Abdul Murad
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

4.  On-chip 3D neuromuscular model for drug screening and precision medicine in neuromuscular disease.

Authors:  Tatsuya Osaki; Sebastien G M Uzel; Roger D Kamm
Journal:  Nat Protoc       Date:  2020-01-13       Impact factor: 13.491

5.  Quantification of Retinogenesis in 3D Cultures Reveals Epigenetic Memory and Higher Efficiency in iPSCs Derived from Rod Photoreceptors.

Authors:  Daniel Hiler; Xiang Chen; Jennifer Hazen; Sergey Kupriyanov; Patrick A Carroll; Chunxu Qu; Beisi Xu; Dianna Johnson; Lyra Griffiths; Sharon Frase; Alberto R Rodriguez; Greg Martin; Jiakun Zhang; Jongrye Jeon; Yiping Fan; David Finkelstein; Robert N Eisenman; Kristin Baldwin; Michael A Dyer
Journal:  Cell Stem Cell       Date:  2015-07-02       Impact factor: 24.633

6.  Identification of a foetal epigenetic compartment in adult human kidney.

Authors:  John K Wiencke; Ze Zhang; Devin C Koestler; Lucas A Salas; Annette M Molinaro; Brock C Christensen; Karl T Kelsey
Journal:  Epigenetics       Date:  2021-03-30       Impact factor: 4.528

7.  Connectivity and circuitry in a dish versus in a brain.

Authors:  Vorapin Chinchalongporn; Peter Koppensteiner; Deborah Prè; Wipawan Thangnipon; Leonilda Bilo; Ottavio Arancio
Journal:  Alzheimers Res Ther       Date:  2015-06-04       Impact factor: 6.982

8.  Distinct Neurodegenerative Changes in an Induced Pluripotent Stem Cell Model of Frontotemporal Dementia Linked to Mutant TAU Protein.

Authors:  Marc Ehrlich; Anna-Lena Hallmann; Peter Reinhardt; Marcos J Araúzo-Bravo; Sabrina Korr; Albrecht Röpke; Olympia E Psathaki; Petra Ehling; Sven G Meuth; Adrian L Oblak; Jill R Murrell; Bernardino Ghetti; Holm Zaehres; Hans R Schöler; Jared Sterneckert; Tanja Kuhlmann; Gunnar Hargus
Journal:  Stem Cell Reports       Date:  2015-07-02       Impact factor: 7.765

Review 9.  Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.

Authors:  Juan Yang; Song Li; Xi-Biao He; Cheng Cheng; Weidong Le
Journal:  Mol Neurodegener       Date:  2016-05-17       Impact factor: 14.195

10.  Factor-Reduced Human Induced Pluripotent Stem Cells Efficiently Differentiate into Neurons Independent of the Number of Reprogramming Factors.

Authors:  Andreas Hermann; Jeong Beom Kim; Sumitra Srimasorn; Holm Zaehres; Peter Reinhardt; Hans R Schöler; Alexander Storch
Journal:  Stem Cells Int       Date:  2016-02-09       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.